Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer

Fig. 3

Kaplan-Meier curves showing the association between IO score and one-year PFS in patients receiving ICI monotherapy with either (A) all patients who received ICI monotherapy (n = 57) or (B) negative or low PD-L1 TPS (0–49%, n = 20). Significance values calculated by log-rank test. PFS, progression-free survival

Back to article page